DSPE-PEG-Ald is a highly specialized and versatile molecule that has gained considerable attention in pharmaceutical research and development due to its unique functional groups and properties. This molecule is a derivative of phospholipids, with a long-chain alkyl group on one end and an aldehyde group on the other, which is linked to a PEG (polyethylene glycol) chain. The alkyl group of DSPE-PEG-Ald is highly hydrophobic, making it suitable for drug delivery applications, while the aldehyde group can react with other biomolecules, allowing for targeted drug delivery and imaging.
DSPE-PEG-Ald has been extensively studied and applied in various pharmaceutical research fields such as cancer therapy, gene delivery, and vaccine development. In cancer therapy, DSPE-PEG-Ald has been used as a carrier for chemotherapeutic agents, enabling targeted drug delivery to cancer cells while minimizing the impact on healthy cells. In gene delivery, the aldehyde group of DSPE-PEG-Ald can be used to conjugate DNA or RNA, facilitating the delivery of therapeutic genes to target cells. Additionally, DSPE-PEG-Ald has shown promise as an adjuvant in vaccine development, where it can enhance immune response and improve the efficacy of vaccines.
In conclusion, DSPE-PEG-Ald is a crucial molecule in pharmaceutical research and development due to its unique functional groups and properties. Its versatility and compatibility with various biomolecules make it an attractive candidate for drug delivery and other biomedical applications. The application of DSPE-PEG-Ald in pharmaceutical research and development has the potential to improve drug efficacy and reduce side effects, leading to better healthcare outcomes for patients.
|AP13637||DSPE-PEG-Ald, MW 1K||1000||≥95%||Pricing|
|AP13665||DSPE-PEG-Ald, MW 2K||2000||≥95%||Pricing|
|AP13680||DSPE-PEG-Ald, MW 3.4K||3400||≥95%||Pricing|
|AP13690||DSPE-PEG-Ald, MW 5K||5000||≥95%||Pricing|